TAGP yields 2000.00% · PFE yields 6.13%● Live data
📍 TAGP pulled ahead of the other in Year 1
Combined, TAGP + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TAGP + PFE for your $10,000?
Tristar Acquisition Group operates as an engineering, procurement, and construction contractor. The company, through its subsidiaries, engages in the design, fabrication, and installation of specialized equipment, known as packages or skids, and production plants for the oil and gas industry and engineering companies. It also designs, manufactures, and markets oil and gas production equipments and systems primarily for the oil and gas production separation process. The company's products and services are used for the separation of unprocessed hydrocarbon fluids into sellable oil and gas, as well as used in the production of crude oil and natural gas to separate oil, gas, and water within a production stream and to remove contaminants. Its products and services are also deployed in downstream operations, such as in refining units, pipeline, LNG liquefaction, and electric generation; and in upstream operations, including wellhead completion, collection center, the first treatment unit, and the process treatment unit. Tristar Acquisition Group installs its products on onshore facilities, as well as in offshore floating production, storage, and offloading vessels. It offers its products primarily in Belarus, Italy, Egypt and the Middle East, the United States, and internationally. Tristar Acquisition Group is headquartered in Rome, Italy.
Full TAGP Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.